Depomed reported $12.39M in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Aerie Pharmaceuticals AERI:US USD -26672000 8.54M
Ani Pharmaceuticals ANIP:US USD -3454000 6.78M
Aurora Cannabis Inc ACB:CN CAD -73026000 13.79M
Cara Therapeutics CARA:US USD -23845000 19.37M
Daiichi Sankyo 4568:JP JPY 61.2B 26.82B
Ironwood Pharmaceuticals IRWD:US USD 68.47M 12.82M
Johnson & Johnson JNJ:US USD 6.77B 173M
Knight Therapeutics Inc GUD:CN CAD -9934000 12.27M
Merk MRK:US USD 5.56B 156M
Nektar Therapeutics NKTR:US USD -37471000 10.24M
Omeros OMER:US USD -50766000 13.33M
Pfizer PFE:US USD 9.7B 2.43B
Teva Pharmaceutical TEVA:IT USD 740M 6M